Efficacy and safety on prophylactic oral steroid and minocycline for rash in patients treated with Erlotinib
Phase 2
Recruiting
- Conditions
- on-Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000005236
- Lead Sponsor
- Toho University Medical Cencer Sakura Hospital, Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with at least one of the following conditions are ineligible 1) Patients with idiopathic pulmonary fibrosis, other interstitial pneumonia, pneumoconiosis, active radiation pneumonitis, drug induced pulmonary damage 2) Patients unable to be treated with PO drugs 3) Clinically significant eye diseases such as severe dry eye, keratoconjunctivitis 4) Pregnancy, breast feeding and suspected pregnancy 5) Active synchronous malignancies 6) Other clinically significant complications 7) History of hypersensitivity for drugs used for this study and tetracyclines antibiotics Other conditions inadequate for this research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method